Fingrut, MD, assistant professor of stem cell transplantation and cellular therapy at The University of Texas MD Anderson Cancer Center. Stem cell donations can be done in different ways ...

This paper investigates how isoform II of transcription factor RUNX2 promotes cell survival and proliferation in oral squamous cell carcinoma cell lines. The authors used gain and loss of function ...

The basal state co-expresses both epithelial and mesenchymal programs and has a distinct epigenetic landscape with accessible chromatin across gene sets that mark cancer cell states with divergent ...

Now visualized using cryo-electron microscopy, the carrier’s lock-like mechanism could be the key to tackling diseases like cancer, diabetes ... it needs to be transferred inside the cell’s ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

A new discovery could pave the way for more effective cancer treatment by helping certain ... to improve their ability to slip through cell membranes by passive diffusion. But the new strategy ...

researchers delivered 7.7 to 22.3 times more of the drug inside cancer cells, making the treatment up to 23 times more potent than before, according to the study published April 17 in Cell.

they were able to deliver between 7.7 and 22.3 times more of the drug into cancer cells – making the treatment up to 23 times more effective, according to a study published today (April 17) in Cell.

Researchers found pyronaridine disrupts an enzyme critical to cellular division and can cause cancer cell death. Additionally, the drug has not been shown to cause significant adverse events in ...

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically significant and clinically meaningful improvement in overall survival compared ...

Early results show the treatment is safe and may improve Parkinson’s symptoms. A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment ...

1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...